pharma.markets

  • HOME
  • Imprint

apps

Coronavirus: EU Member States agree on an interoperability solution for mobile tracing and warning apps

16/06/2020 MaP 0

Member States, with the support of the Commission, have agreed on a set of technical specifications to ensure a safe exchange of information between national […]

Coronavirus: a common approach for safe and efficient mobile tracing apps across the EU

13/05/2020 MaP 0

What is a contact tracing and warning app? A contact tracing and warning app is voluntarily installed and used to warn users if they have […]

Coronavirus: EU Commission publishes guidance to ensure full data protection standards of apps fighting the pandemic

17/04/2020 MaP 0

The Commission has published guidance on the development of new apps that support the fight against coronavirus in relation to data protection. The development of […]

Coronavirus: An EU approach for efficient contact tracing apps to support gradual lifting of confinement measures

16/04/2020 MaP 0

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response […]

Coronavirus: EU Commission adopts Recommendation to support exit strategies through mobile data and apps

08/04/2020 MaP 0

Today, the Commission recommends steps and measures to develop a common EU approach for the use of mobile applications and mobile data in response to […]

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines
  • Valencia Comunidad

Reports

  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
  • Spain – The vaccination schedule: when will we be vaccinated?
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

Archive

  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents

    09/04/2021 0
  • Spain – The vaccination schedule: when will we be vaccinated?

    07/04/2021 0
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months

    01/04/2021 0
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus

    30/03/2021 0
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

    26/03/2021 0
Archives
  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support test vaccine

Copyright © 2021 | WordPress Theme by MH Themes